Dr. Juan Bonilla, MD

General Surgery  ·  
Male  ·  
Age 57
(4)
Insurances Accepted  ·  Save
Dr. Juan Bonilla, MD
Dr. Juan Bonilla, MD is a general surgery specialist in Indianapolis, IN and has been practicing for 29 years. He graduated from University Of Chicago/The Pritzker School Of Medicine in 1989 and specializes in general surgery, thoracic surgery, and more.

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

5255 E Stop 11 Rd

Indianapolis, IN 46237

Contact Information

(317) 851-2323

Dr. Juan Bonilla, MD

Dr. Juan Bonilla, MD

Accepted insurance

  • Aetna
  • Anthem Blue Cross Blue Shield
  • Blue Cross Blue Shield
  • Cigna
  • Coventry Health Care
  • First Health (Coventry Health Care)
  • HAP Insurance
  • HealthLink
  • Humana
  • MultiPlan
  • Priority Health
  • Sagamore Health Network

*Please verify this information when scheduling an appointment.

Learn about Dr. Bonilla

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Top Care Areas

See how frequently Dr. Bonilla performs your care needs compared to other doctors.

Coronary Artery Bypass Graft (CABG) Surgery
high
more than 80% of peers
Coronary Artery Disease (CAD)
normal
more than 79% of peers
Vascular Disease
normal
more than 76% of peers

Dr. Bonilla's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

3  Specialties

  • General Surgery
  • Cardiothoracic Surgery
  • Thoracic Surgery

1  Board Certifications

  • Thoracic Cardiovascular Surgery
    Accredited by: American Board of Thoracic Surgery*

45  Conditions Treated

  • Aneurysm
  • Angina and Acute Coronary Syndrome
  • Aortic Aneurysm
  • Aortic Dissection
  • Aortic Ectasia
  • Aortic Stenosis
  • Aortic Valve Disease
  • Aortic Valve Regurgitation
  • Arrhythmias
  • Atrial Fibrillation
  • Atrial Flutter
  • Benign Tumor
  • Cancer
  • Cardiomegaly
  • Cardiomyopathy
  • Cardiovascular Disease
  • Carotid Artery Disease
  • Coarctation of the Aorta
  • Congenital Heart Defects
  • Congenital Heart Disease
  • Coronary Artery Disease (CAD)
  • Coronary Artery Dissection
  • Empyema
  • Endocarditis
  • Esophageal Diseases
  • Heart Attack (Acute Myocardial Infarction)
  • Heart Block
  • Heart Disease
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Mitral Valve Disease
  • Mitral Valve Regurgitation
  • Mitral Valve Stenosis
  • Pericardial Disease
  • Peripheral Arterial Aneurysm
  • Peripheral Arterial Aneurysm and Dissection
  • Peripheral Arterial Dissection
  • Pleural Cancer
  • Pulmonary Disease
  • Pulmonary Embolism
  • Pulmonary Valve Disease
  • Ruptured Aortic Aneurysm
  • Septal Defect
  • Thrombosis
  • Vascular Disease
Less
Read Less

45  Procedures

Less
Read Less

Background Check

Malpractice Claims not available

Healthgrades does not collect malpractice information for Indiana.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • University Of Chicago/The Pritzker School Of Medicine
    Medical School | Graduated 1989
  • Loyola University
    Fellowship Hospital | Completed

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
Media & Publications

Dr. Bonilla has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Bonilla does not have any memberships or affiliations listed. If you are Dr. Bonilla and would like to add memberships or affiliations, please update your profile.

Dr. Bonilla's Reviews

Likelihood to recommend Dr. Bonilla

5.0

Based on 4 reviews

5 Stars
100%
(4)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Bonilla?
(Select your rating)
Average Wait Time
  • 10 – 15 minutes
Dr. Bonilla's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness

Leave a review

How was your experience with Dr. Bonilla?

Locations

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Aetna
Aetna HMO
Choice Plus POS II
Anthem Blue Cross Blue Shield
Anthem Blue Cross Blue Shield HMO
Anthem Blue Cross Blue Shield PPO
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
Coventry Health Care
Coventry Health America PPO
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
HAP Insurance
Preferred PPO
HealthLink
HealthLink PPO
Humana
Choice Care PPO
Preferred PPO
MultiPlan
MultiPlan PPO
PHCS Network PPO
Priority Health
Priority PPO
Sagamore Health Network
Sagamore Plus

Affiliated Hospitals

Check the quality of care at hospitals Dr. Bonilla is affiliated with. For more detailed ratings based on patient outcomes, view the hospital's profile.

Learn more